MYC represents another gene frequently overexpressed in many tumors [45], and its role in promoting metabolic reprogramming has been reported in several cancer types, including colorectal [46], pancreatic [47], breast [48], prostate cancer [49], and glioma [50]. This evidence concerns the gene MYC and Familial prostate cancer.